These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34222003)

  • 1. Establishment of a Prognostic Nomogram for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Incorporating TNM Stage, Post-Induction Chemotherapy Tumor Volume and Epstein-Barr Virus DNA Load.
    Jiang YT; Chen KH; Yang J; Liang ZG; Qu S; Li L; Zhu XD
    Front Oncol; 2021; 11():683475. PubMed ID: 34222003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
    Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study.
    OuYang PY; You KY; Zhang LN; Xiao Y; Zhang XM; Xie FY
    Cancer Commun (Lond); 2018 Sep; 38(1):55. PubMed ID: 30176932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of integrating tumor volume and plasma Epstein-Barr virus DNA load during sequential chemoradiotherapy for prognostic prediction and therapeutic guidance in high-risk locoregionally advanced nasopharyngeal carcinoma.
    Wang G; Dong Z; Huang C; Du X; Chen L; Li K; Guo R; Tang L; Ma J
    Oral Oncol; 2023 Oct; 145():106500. PubMed ID: 37467683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
    Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
    JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic efficacy of the combination of the pretreatment systemic Immune-Inflammation Index and Epstein-Barr virus DNA status in locally advanced Nasopharyngeal Carcinoma Patients.
    Xiong Y; Shi LL; Zhu LS; Ding Q; Ba L; Peng G
    J Cancer; 2021; 12(8):2275-2284. PubMed ID: 33758605
    [No Abstract]   [Full Text] [Related]  

  • 8. Nomogram for distant metastasis-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yang H; Zhang R; Zhang R; Zhang B; Xie Y; Qin G; Mo Y; Ruan X; Jiang W
    Strahlenther Onkol; 2022 Sep; 198(9):828-837. PubMed ID: 35384452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of radiologic extranodal extension in locoregionally advanced nasopharyngeal carcinoma with lymph node metastasis: a comprehensive nomogram.
    Ding J; Chen J; Lin Y; Hong J; Huang C; Fei Z; Chen C
    Braz J Otorhinolaryngol; 2024; 90(2):101363. PubMed ID: 38101121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a prognostic nomogram for patients with locoregionally advanced nasopharyngeal carcinoma incorporating clinical characteristics and dynamic changes in hematological and inflammatory markers.
    Liu Q; Ma L; Ma H; Yang L; Xu Z
    Front Oncol; 2022; 12():1032213. PubMed ID: 36387244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of immune-inflammatory and nutrition indicators in non-metastatic nasopharyngeal carcinoma with negative plasma Epstein-Barr virus DNA.
    Weng Y; Wu L; Li Y; Wang J; Wu Z; Hong X; Liu X; Lai J; Lu J; Qiu S
    Ther Adv Med Oncol; 2024; 16():17588359241286489. PubMed ID: 39403452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram Based on Inflammatory Biomarkers and Nutritional Indicators for Predicting Overall Survival in Locoregionally Advanced Nasopharyngeal Carcinoma.
    Zhao R; Liang Z; Chen K; Zhu X
    J Inflamm Res; 2022; 15():2971-2981. PubMed ID: 35602661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram incorporating Epstein-Barr virus DNA and a novel immune-nutritional marker for survival prediction in nasopharyngeal carcinoma.
    Wu S; Yuan X; Huang H; Li Y; Cui L; Lin D; Lu W; Feng H; Chen Z; Liu X; Tan J; Wang F
    BMC Cancer; 2023 Dec; 23(1):1217. PubMed ID: 38066499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
    Sun XS; Xiao ZW; Liu SL; Sun R; Luo DH; Chen QY; Mai HQ
    Eur Radiol; 2023 May; 33(5):3682-3692. PubMed ID: 36735041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Nomogram Based on Serum Biomarkers and Clinical Characteristics to Predict Survival in Patients With Non-Metastatic Nasopharyngeal Carcinoma.
    Li QJ; Mao YP; Guo R; Huang CL; Fang XL; Ma J; Tang LL; Chen L
    Front Oncol; 2020; 10():594363. PubMed ID: 33363024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nomogram based on tumor response to induction chemotherapy may predict survival in locoregionally advanced nasopharyngeal carcinoma.
    Jiang YT; Chen KH; Liang ZG; Yang J; Wei SQ; Qu S; Li L; Zhu XD
    Head Neck; 2022 Jun; 44(6):1301-1312. PubMed ID: 35212066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Sarcopenia to Predict Survival for Patients With Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy.
    Hua X; Li WZ; Huang X; Wen W; Huang HY; Long ZQ; Lin HX; Yuan ZY; Guo L
    Front Oncol; 2021; 11():625534. PubMed ID: 33777769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dynamic nomogram combining tumor stage and magnetic resonance imaging features to predict the response to induction chemotherapy in locally advanced nasopharyngeal carcinoma.
    Jiang Y; Liang Z; Chen K; Li Y; Yang J; Qu S; Li L; Zhu X
    Eur Radiol; 2023 Mar; 33(3):2171-2184. PubMed ID: 36355201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic nutritional index represents a novel inflammation-nutrition-based prognostic factor for nasopharyngeal carcinoma.
    Jiang YM; Huang ST; Pan XB; Ma JL; Zhu XD
    Front Nutr; 2023; 10():1036572. PubMed ID: 36875852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.